Esoterix Genetic Laboratories | GenomeWeb

Esoterix Genetic Laboratories

Esoterix sued Myriad in September, claiming that its myRisk Hereditary Cancer panel and services directly infringe four patents it has exclusively licensed.

NEW YORK (GenomeWeb) – The recent lawsuit filed by Esoterix Genetic Laboratories against Qiagen over an alleged breached licensing agreement covering EGFR testing may be a message to other labs who have sold tests without a license.

NEW YORK (GenomeWeb) – LabCorp subsidiary Esoterix Genetic Laboratories is suing Qiagen in a US district court alleging that Qiagen breached a licensing agreement between the companies regarding EGFR genetic testing by offering it for commercial research and diagnostic purposes ahead of US Food a

Canon US Life Sciences has been awarded US Patent No. 8,409,848, "System and method for rapid thermal cycling."
Shulin Zeng, Kenton Hasson, Gregory Dale, and John Keady are named as inventors.

The Biological Research Center of the Hungarian Academy of Sciences and Glaxo Group Limited, a subsidiary of GlaxoSmithKline, have been jointly awarded US Patent No. 8,389,802, "Artificial chromosomes, uses thereof, and methods for preparing artificial chromosomes.

NEW YORK (GenomeWeb News) – Life Technologies reported after the close of the market on Thursday that a jury has found it guilty of infringing Enzo Biochem's patents and awarded Enzo $48.6 million.

NEW YORK (GenomeWeb News) – Esoterix Genetic Laboratories has filed a suit against Life Technologies alleging that the firm and its Applied Biosystems and Ion Torrent businesses infringe three patents held by Esoterix.

MUSC Foundation for Research Development, Esoterix Genetic Laboratories, and Roche Molecular Systems win US patents.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.